Harte-Hanks (NASDAQ: HHS) reported Q3 EPS of $0.02, $0.20 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $47.63 million versus the consensus estimate of $47.2 million.

For earnings history and earnings-related data on Harte-Hanks (HHS) click here.